Metabolic Hormones and Regulation of Synaptic Function: Implications for Health and CNS Disease

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".

Deadline for manuscript submissions: closed (15 May 2022) | Viewed by 399

Special Issue Editor


E-Mail Website
Guest Editor
Systems Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK
Interests: leptin; synaptic plasticity; AMPA receptor trafficking; Alzheimer's disease; cannabinoids; estrogens

Special Issue Information

Dear Colleagues,

The peripheral actions of metabolic hormones, such as insulin, leptin, and ghrelin, are well established. However, increasing evidence indicates that the actions of these hormones is not restricted to peripheral tissues, as numerous studies have revealed that these hormones can readily access the CNS and modulate the functioning of synapses. The hippocampus is a brain region that is pivotally involved in learning and memory processes, such that activity-dependent changes in the strength of hippocampal excitatory synapses underlie formation of spatial and episodic learning and memory. However, the hippocampus is also an extremely vulnerable area of the brain, with a high susceptibility to seizure generation, and it is an early site for degeneration in age-related neurodegenerative disorders. Recent evidence indicates that the hippocampus, and specifically hippocampal excitatory synapses are markedly influenced by hormonal systems, with many metabolic hormones linked to pro-cognitive actions. However, on the flip side, age-related impairments in metabolic hormone function are associated with an increased risk of CNS disease, including neurodegenerative disease. In this Special Issue, the ability of metabolic hormones to regulate hippocampal synaptic function and the consequences for brain health and CNS-driven disease will be explored.

Dr. Jenni Harvey
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop